Source: News Bharati English20 Mar 2017 12:00:16
Los Angeles, March 20: A month ago the SpaceX Dragon Capsule which was launched in the International Space Station returned back to the Earth on Sunday loaded with full of space station science samples. The SpaceX Dragon Capsule was parachuted into the Pacific Ocean safely which carried 5400 pounds of cargo and samples from important experiments carried out by the scientists.
At about 5 a.m. ET, the Dragon capsule was released from the Space Station. Approximately five hours later, the capsule re-entered Earth’s orbit. At around 10:45 ET, SpaceX also confirmed that the capsule had successfully splashed down off the west coast of Baja, California.
The SpaceX Dragon Capsule carries the samples from the experiments which are carried out by the scientists at the Space Station which includes Microgravity Expanded Stem Cells investigation and the Tissue Regeneration-Bone Defect study. Now the SpaceX Capsule will be recovered and will also be prepped up for a return trip to the Space Station as many of the samples carried by it will be sent back to NASA.
NASA stated that the Microgravity Expanded Stem Cells investigation had crew members observe cell growth and other characteristics in microgravity. This information will provide insight into how human cancers start and spread, which aids in the development of prevention and treatment plans. Results from this investigation could lead to the treatment of disease and injury in space, as well as provide a way to improve stem cell production for human therapy on Earth, NASA said on its website.
Also, the Tissue Regeneration-Bone Defect study, which is a U.S. National Laboratory investigation, aims to explore why humans and other animals can’t regenerate bones and whether being in microgravity could actually allow for that regeneration.“Results will provide a new understanding of the biological reasons behind a human’s inability to grow a lost limb at the wound site, and could lead to new treatment options for the more than 30% of the patient population who do not respond to current options for chronic non-healing wounds.”